Rates and risk factors for drug resistance tuberculosis in Northeastern China

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Liu, Qiao ^a   Zhu, Limei ^a   Shao, Yan ^a   Song, Honghuan ^a   Li, Guoli ^a   Zhou, Yang ^a   Shi, Jinyan ^b   Zhong, Chongqiao ^b   Chen, Cheng ^a   Lu, Wei ^a  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Department of Chronic Communicable Disease Center for Disease Control and Prevention of Lianyungang City   (China)

Author keywords

Drug resistance; Drug susceptibility; Epidemiology; MDR TB

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGE; AGED; ARTICLE; CHINA; DRUG EFFECT; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; MALE; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; ANTITUBERCULAR AGENTS; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; RISK FACTORS; SEX FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84889957817     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-1171     Document Type: Article

References (37)

1. WHO, World Health Organization: Global tuberculosis control WHO report 2012 http://wwwwhoint/tb/publications/global-report/gtbr12-mainpdf 2012, website WHO report
2. National survey of drug-resistant tuberculosis in China. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, N Engl J Med 2012 366 23 2161 2170
3. Hypervariable loci that enhance the discriminatory ability of newly proposed 15loci and 24loci variablenumber tandem repeat typing method on Mycobacterium tuberculosis strains predominated by the Beijing family. Iwamoto T, Yoshida S, Suzuki K, Tomita M, Fujiyama R, Tanaka N, Kawakami Y, Ito M, FEMS Microbiol Lett 2007 270 1 67 74 (Pubitemid 46597342)
4. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Glynn J, Vyonycky E, Fine P, Am J Epidemiol 1999 149 4 366 371 (Pubitemid 29302110)
5. Organization WH, Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response Geneva: World Health Organization 2010
6. National anti-tuberculosis drug resistance study in Tanzania. Chonde T, Basra D, Mfinanga S, Range N, Lwilla F, Shirima R, Van Deun A, Zignol M, Cobelens F, Egwaga S, Int J Tuberc Lung Dis 2010 14 8 967 972
7. Drug resistance pattern of mycobacterium tuberculosis complex at a Medical Center in Central Taiwan, 2003-2007. Yu C-C, Chang C-Y, Liu C-E, Shih L-F, Hsiao J-H, Chen C-H, J Microbiol Immunol Infect 2010 43 4 285 290
8. Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead. Shao Y, Yang D, Xu W, Lu W, Song H, Dai Y, Shen H, Wang J, BMC Public Health 2011 11 110
9. Molecular typing of mycobacterium tuberculosis isolates circulating in Jiangsu Province, China. Liu Q, Yang D, Xu W, Wang J, Lv B, Shao Y, Song H, Li G, Dong H, Wan K, et al. BMC Infect Dis 2011 11 288
10. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China [Short communication]. Li X, Wang H, Jing H, Wang Y, Yu C, Wang J, Liu Z, Graviss E, Ma X, Int J Tuberc Lung Dis 2012 16 5 612 614
11. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, Xu B, Microb Drug Resist 2008 14 3 227 232
12. Drug-resistant tuberculosis in Shanghai, China, 2000-2006: prevalence, trends and risk factors. Shen X, DeRiemer K, Yuan Z-A, Shen M, Xia Z, Gui X, Wang L, Gao Q, Mei J, Int J Tuberc Lung Dis 2009 13 2 253 259
13. Drug resistance rates of Mycobacterium tuberculosis at a private referral center in Korea. Choi JC, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Lee NY, Park YK, Bai GH, Koh W-J, J Korean Med Sci 2007 22 4 677 681
14. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua. Chacón L, Laínez M, Rosales E, Mercado M, Caminero J, Int J Tuberc Lung Dis 2009 13 1 62 67
15. Tuberculosis in aging adults. Yoshikawa T, J Am Geriatr Soc 1992 40 2 178
16. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K, Hoffner S, Drobniewski F, Barrera L, van Soolingen D, Lancet 2009 373 9678 1861 1873
17. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation [Review article]. Caminero J, Int J Tuberc Lung Dis 2008 12 8 869 877
18. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Dye C, Nat Rev Microbiol 2009 7 1 81 87
19. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Kim H-R, Hwang SS, Kim HJ, Lee SM, Yoo C-G, Kim YW, Han SK, Shim Y-S, Yim J-J, Clin Infect Dis 2007 45 10 1290 1295 (Pubitemid 351418994)
20. Extensively drug-resistant tuberculosis in California, 1993-2006. Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J, Clin Infect Dis 2008 47 4 450 457
21. Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan. Jou R, Chiang CY, Huang WL, J Clin Microbiol 2005 43 1 95 100 (Pubitemid 40096285)
22. Organization WH, Engaging all health care providers in TB control: guidance on implementing public-private mix approaches Geneva: World Health Organization 2006
23. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T, Int J Tuberc Lung Dis 2004 8 1 31 38 (Pubitemid 38120703)
24. Initial drug resistance and tuberculosis treatment outcomes. Lew W, Pai M, Oxlade O, Ann Intern Med 2008 149 123 134
25. Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Mak A, Thomas A, del Granado M, Zaleskis R, Mouzafarova N, Menzies D, Am J Respir Crit Care Med 2008 178 3 306 312
26. Prevalence and risk factors for drug resistance among hospitalized TB patients in Georgia. Vashakidze L, Salakaia A, Shubladze N, Cynamon M, Barbakadze K, Kikvidze M, Papitashvili L, Nonikashvili M, Solomonia N, Bejanishvili N, Int J Tuberc Lung Dis 2009 13 9 1148
27. High prevalence of multidrug-resistant tuberculosis in Georgia. Mdivani N, Zangaladze E, Volkova N, Kourbatova E, Jibuti T, Shubladze N, Kutateladze T, Khechinashvili G, del Rio C, Salakaia A, Int J Infect Dis 2008 12 6 635
28. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Toungoussova O, Caugant D, Sandven P, Mariandyshev A, Bjune G, Int J Tuberc Lung Dis 2002 6 5 406 414 (Pubitemid 34492164)
29. Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis. Lockman S, Kruuner A, Binkin NJ, Levina K, Wang YC, Danilovitsh M, Hoffner SE, Tappero JW, Clin Infect Dis 2001 32 3 373 380 (Pubitemid 32173622)
30. Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan. Chiang C, Chang C, Chang R, Li C, Huang R, Int J Tuberc Lung Dis 2005 9 9 1006 1012 (Pubitemid 41549188)
31. Longer delays in tuberculosis diagnosis among women in Vietnam. Long NH, Johansson E, Lonnroth K, Eriksson B, Winkvist A, Diwan V, Int J Tuberc Lung Dis 1999 3 5 388 393 (Pubitemid 29294688)
32. Extensively drugresistant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Jeon CY, Hwang SH, Min JH, Prevots DR, Goldfeder LC, Lee H, Eum SY, Jeon DS, Kang HS, Kim JH, Clin Infect Dis 2008 46 1 42 49 (Pubitemid 351263558)
33. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Faustini A, Hall AJ, Perucci CA, Thorax 2006 61 2 158 163 (Pubitemid 43235434)
34. Risk factors for multidrug-resistant tuberculosis in Hong Kong. Law W, Yew W, Chiu Leung C, Kam K, Tam C, Chan C, Leung C, Int J Tuberc Lung Dis 2008 12 9 1065 1070
35. Risk factors for acquired multidrug-resistant tuberculosis. Barroso EC, Mota RMS, Santos RO, Sousa ALO, Barroso JB, Rodrigues JLN, J Pneumol 2003 29 2 89 97
36. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G, Lancet 2006 368 9547 1575 1580 (Pubitemid 44780738)
37. Underreported threat of multidrug-resistant tuberculosis in Africa. Amor YB, Nemser B, Singh A, Sankin A, Schluger N, Emerg Infect Dis 2008 14 9 1345